VAERS reports by lot

GSK Varicella/Shingles lot 2JA2N: VAERS reports

27 VAERS reports list lot 2JA2N as a GSK Varicella/Shingles vaccine, received between 2022-08-29 and 2024-05-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1244%
Neurological622%
Cardiac / Cardiovascular311%
General / Systemic (non-local)27%
Gastrointestinal14%
Musculoskeletal14%
Dermatological (non-injection-site)14%
Psychiatric / Neuropsychiatric14%

Where reports came from

U.S. state of the reporter, where given (top 9).

District of Columbia11
New York2
Michigan2
Wisconsin2
Virginia2
Massachusetts1
Ohio1
Connecticut1
Missouri1

Reports by month received

2022-082
2022-111
2022-121
2023-013
2023-022
2023-042
2023-111
2023-124
2024-013
2024-025
2024-053

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.